179 related articles for article (PubMed ID: 7837915)
41. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
42. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
43. Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma.
Gallo O; Pinto S; Boccuzzi S; Dilaghi M; Gallina E; Attanasio M; Gori AM; Martini F; Abbate R
Laryngoscope; 1992 Apr; 102(4):447-50. PubMed ID: 1556897
[TBL] [Abstract][Full Text] [Related]
44. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck.
Rinaldo A; Devaney KO; Ferlito A
ORL J Otorhinolaryngol Relat Spec; 2004; 66(1):38-41. PubMed ID: 15103200
[TBL] [Abstract][Full Text] [Related]
46. [Prostaglandin-E2 (PGE2) and interleukin-1 (IL-1) production from plastic-adherent peripheral blood mononuclear cells, and serum and urinary glucocorticoid levels in cancer patients treated with systemic chemotherapy--with special reference to circadian rhythm of serum cortisol levels in cancer].
Ito K; Asai R; Nakao I; Ohashi Y; Kataoka T; Saito T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):489-93. PubMed ID: 2321978
[TBL] [Abstract][Full Text] [Related]
47. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma.
Kumagai K; Hamada Y; Gotoh A; Kobayashi H; Kawaguchi K; Horie A; Yamada H; Suzuki S; Suzuki R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):341-50. PubMed ID: 20598595
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.
Loose D; Signore A; Bonanno E; Vermeersch H; Dierckx R; Deron P; Van de Wiele C
Cancer Biother Radiopharm; 2008 Feb; 23(1):25-33. PubMed ID: 18298326
[TBL] [Abstract][Full Text] [Related]
49. Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis.
Kline ER; Muller S; Pan L; Tighiouart M; Chen ZG; Marcus AI
Head Neck; 2011 Oct; 33(10):1501-12. PubMed ID: 21928424
[TBL] [Abstract][Full Text] [Related]
50. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
51. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical localization of basement membrane type IV collagen in invasive and metastatic squamous carcinomas of the head and neck.
Carter RL; Burman JF; Barr L; Gusterson BA
J Pathol; 1985 Nov; 147(3):159-64. PubMed ID: 4067734
[TBL] [Abstract][Full Text] [Related]
53. Phospholipid metabolite expression by head and neck squamous cell carcinoma.
Mann EA; Spiro JD; Chen LL; Kreutzer DL
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):763-9. PubMed ID: 8018329
[TBL] [Abstract][Full Text] [Related]
54. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
55. Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma.
Thiel A; Kesselring R; Pries R; Wittkopf N; Puzik A; Wollenberg B
Oncol Rep; 2011 Sep; 26(3):615-20. PubMed ID: 21687955
[TBL] [Abstract][Full Text] [Related]
56. [Cytodiagnosis of lymph node metastases in the region of the head and neck].
Müller HA
Pathologe; 1984 Oct; 5(5):247-51. PubMed ID: 6095242
[No Abstract] [Full Text] [Related]
57. Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Liu Y; Xie C; Zhang X; Huang D; Zhou X; Tan P; Qi L; Hu G; Tian Y; Qiu Y
Eur J Cancer; 2010 Nov; 46(16):3007-15. PubMed ID: 20724142
[TBL] [Abstract][Full Text] [Related]
58. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.
Kesselring R; Thiel A; Pries R; Wollenberg B
Cell Immunol; 2011; 269(2):74-7. PubMed ID: 21570678
[TBL] [Abstract][Full Text] [Related]
59. [Esophageal carcinoma with hypercalcemia that appeared to be caused by prostaglandin E2 produced by the tumor cells].
Maeda Y; Sasaki T; Mochizuki M; Koike M
Gan No Rinsho; 1990 Nov; 36(14):2445-9. PubMed ID: 2250367
[TBL] [Abstract][Full Text] [Related]
60. Solid tumor preparation for clinical application of flow cytometry.
Ensley JF; Maciorowski Z; Pietraszkiewicz H; Hassan M; Kish J; Al-Sarraf M; Jacobs J; Weaver A; Atkinson D; Crissman J
Cytometry; 1987 Sep; 8(5):488-93. PubMed ID: 3665673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
